Your browser doesn't support javascript.
loading
Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis.
Golhen, Klervi; Winskill, Carolyn; Theiler, Martin; Buettcher, Michael; Yeh, Yu-Hsin; Zhang, Nancy; Welzel, Tatjana; Pfister, Marc.
Afiliação
  • Golhen K; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Winskill C; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Theiler M; Pediatric Skin Center, Dermatology Department, University Children's Hospital Zurich, Zurich, Switzerland.
  • Buettcher M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Yeh YH; Pediatric Infectious Diseases Unit, Pediatric Department, Children's Hospital - Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Zhang N; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Welzel T; Integrated Drug Development, Certara LP, Princeton, NJ, United States.
  • Pfister M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Front Med (Lausanne) ; 9: 944208, 2022.
Article em En | MEDLINE | ID: mdl-36226155
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article